Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jun;34(6):1227–1231. doi: 10.1128/aac.34.6.1227

Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users.

P M Small 1, H F Chambers 1
PMCID: PMC171789  PMID: 2393284

Abstract

The clinical courses of 13 consecutive intravenous drug users with Staphylococcus aureus endocarditis treated principally with vancomycin were reviewed. Two patients, one with only right-sided endocarditis and the other with tricuspid and mitral valve endocarditis, had recurrences of positive blood cultures 2 days after completing a 4-week course of vancomycin. Two patients, both of whom eventually were cured, had modifications of therapy because of bacteremia persisting 7 and 16 days into therapy. One patient required an operation for recurrent fevers, and the resected vegetation showed evidence of active infection. Time-kill studies performed with nafcillin and vancomycin for 10 isolates of S. aureus showed that vancomycin was less rapidly bactericidal than nafcillin. Although vancomycin is used as an alternative to penicillinase-resistant penicillins for treatment of staphylococcal endocarditis, these findings raise the question of whether it is equivalent to these drugs in efficacy.

Full text

PDF
1227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams B., Sklaver A., Hoffman T., Greenman R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med. 1979 May;90(5):789–791. doi: 10.7326/0003-4819-90-5-789. [DOI] [PubMed] [Google Scholar]
  2. Barg N. L., Supena R. B., Fekety R. Persistent staphylococcal bacteremia in an intravenous drug abuser. Antimicrob Agents Chemother. 1986 Feb;29(2):209–211. doi: 10.1128/aac.29.2.209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bayer A. S. Staphylococcal bacteremia and endocarditis: state of the art. Arch Intern Med. 1982 Jun;142(6):1169–1177. [PubMed] [Google Scholar]
  4. Cafferkey M. T., Hone R., Keane C. T. Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1985 Dec;28(6):819–823. doi: 10.1128/aac.28.6.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cantoni L., Wenger A., Glauser M. P., Bille J. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis. 1989 May;159(5):989–993. doi: 10.1093/infdis/159.5.989. [DOI] [PubMed] [Google Scholar]
  6. Chambers H. F., Miller R. T., Newman M. D. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two-week combination therapy. Ann Intern Med. 1988 Oct 15;109(8):619–624. doi: 10.7326/0003-4819-109-8-619. [DOI] [PubMed] [Google Scholar]
  7. Cooper R. H., Savitch C. B., Joseph W. P., Mills J. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother. 1981 Feb;19(2):256–259. doi: 10.1128/aac.19.2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Faville R. J., Jr, Zaske D. E., Kaplan E. L., Crossley K., Sabath L. D., Quie P. G. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. JAMA. 1978 Oct 27;240(18):1963–1965. doi: 10.1001/jama.240.18.1963. [DOI] [PubMed] [Google Scholar]
  9. Garaud J. J., Regnier B., Lassoued K., Pangon B., Leport C. Traitement des staphylococcies graves. Echecs de la rifampicine en association. Quatre observations. Presse Med. 1985 May 4;14(18):1013–1016. [PubMed] [Google Scholar]
  10. Geiseler P. J., Rice T. W., McCulley D. J., Lewis S. M., Berzins B. L. Failure of medical therapy in tricuspid endocarditis due to Staphylococcus aureus. Chemotherapy. 1984;30(6):408–412. doi: 10.1159/000238301. [DOI] [PubMed] [Google Scholar]
  11. Geraci J. E., Wilson W. R. Vancomycin therapy for infective endocarditis. Rev Infect Dis. 1981 Nov-Dec;3 Suppl:S250–S258. [PubMed] [Google Scholar]
  12. Gopal V., Bisno A. L., Silverblatt F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. JAMA. 1976 Oct 4;236(14):1604–1606. [PubMed] [Google Scholar]
  13. Greenman R. L., Arcey S. M., Gutterman D. A., Zweig R. M. Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Antimicrob Agents Chemother. 1984 Jan;25(1):16–19. doi: 10.1128/aac.25.1.16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Karchmer A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. doi: 10.1016/0002-9343(85)90374-2. [DOI] [PubMed] [Google Scholar]
  15. Klastersky J., Coppens L., van der Auwera P., Meunier-Carpentier F. Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections. J Antimicrob Chemother. 1983 Apr;11(4):361–367. doi: 10.1093/jac/11.4.361. [DOI] [PubMed] [Google Scholar]
  16. Korzeniowski O., Sande M. A. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med. 1982 Oct;97(4):496–503. doi: 10.7326/0003-4819-97-4-496. [DOI] [PubMed] [Google Scholar]
  17. Levine D. P., Cushing R. D., Jui J., Brown W. J. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med. 1982 Sep;97(3):330–338. doi: 10.7326/0003-4819-97-3-330. [DOI] [PubMed] [Google Scholar]
  18. Massanari R. M., Donta S. T. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest. 1978 Mar;73(3):371–375. doi: 10.1378/chest.73.3.371. [DOI] [PubMed] [Google Scholar]
  19. Menda K. B., Gorbach S. L. Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med. 1973 Jan;78(1):25–32. doi: 10.7326/0003-4819-78-1-25. [DOI] [PubMed] [Google Scholar]
  20. Milatovic D. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? Eur J Clin Microbiol. 1986 Dec;5(6):689–692. doi: 10.1007/BF02013306. [DOI] [PubMed] [Google Scholar]
  21. Parker R. H., Fossieck B. E., Jr Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis. Ann Intern Med. 1980 Dec;93(6):832–834. doi: 10.7326/0003-4819-93-6-832. [DOI] [PubMed] [Google Scholar]
  22. Rajashekaraiah K. R., Rice T., Rao V. S., Marsh D., Ramakrishna B., Kallick C. A. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann Intern Med. 1980 Dec;93(6):796–801. doi: 10.7326/0003-4819-93-6-796. [DOI] [PubMed] [Google Scholar]
  23. Sklaver A. R., Hoffman T. A., Greenman R. L. Staphylococcal endocarditis in addicts. South Med J. 1978 Jun;71(6):638–643. doi: 10.1097/00007611-197806000-00009. [DOI] [PubMed] [Google Scholar]
  24. Sorrell T. C., Packham D. R., Shanker S., Foldes M., Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982 Sep;97(3):344–350. doi: 10.7326/0003-4819-97-3-344. [DOI] [PubMed] [Google Scholar]
  25. Tuazon C. U., Cardella T. A., Sheagren J. N. Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med. 1975 Dec;135(12):1555–1561. [PubMed] [Google Scholar]
  26. Weinstein M. P., Stratton C. W., Ackley A., Hawley H. B., Robinson P. A., Fisher B. D., Alcid D. V., Stephens D. S., Reller L. B. Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med. 1985 Feb;78(2):262–269. doi: 10.1016/0002-9343(85)90436-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES